GILGAMESH PHARMACEUTICALS Trademark
Trademark Overview
On Friday, July 29, 2022, a trademark application was filed for GILGAMESH PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the GILGAMESH PHARMACEUTICALS trademark a serial number of 97526318. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, May 16, 2025. This trademark is owned by GILGAMESH PHARMACEUTICALS, INC.. The GILGAMESH PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely, pharmaceutical and drug preparations and substances for use in treating cancer and for use in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, and longevity; Diagnostic biomarker reagents for pharmaceutical and medical purposes; predictive biomarker reagents for medical use, namely, for pharmaceuticals and drugs for use in treating cancer and in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia,...
General Information
| Serial Number | 97526318 |
| Word Mark | GILGAMESH PHARMACEUTICALS |
| Filing Date | Friday, July 29, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Friday, May 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 26, 2023 |
Trademark Statements
| Goods and Services | Pharmaceuticals, namely, pharmaceutical and drug preparations and substances for use in treating cancer and for use in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, and longevity; Diagnostic biomarker reagents for pharmaceutical and medical purposes; predictive biomarker reagents for medical use, namely, for pharmaceuticals and drugs for use in treating cancer and in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, and longevity |
| NOT AVAILABLE | "PHARMACEUTICALS" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | GILGAMESH PHARMACEUTICALS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10003 |
| Party Name | GILGAMESH PHARMACEUTICALS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10003 |
Trademark Events
| Event Date | Event Description |
| Tuesday, August 2, 2022 | NEW APPLICATION ENTERED |
| Tuesday, August 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 16, 2023 | ASSIGNED TO EXAMINER |
| Thursday, May 25, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, May 25, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, May 25, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 18, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, August 18, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 18, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 18, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 21, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 26, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 26, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, September 6, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 21, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Saturday, May 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 17, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, May 17, 2024 | SOU EXTENSION 1 FILED |
| Friday, May 17, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 21, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 21, 2024 | SOU EXTENSION 2 FILED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, November 22, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, May 16, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 16, 2025 | SOU EXTENSION 3 FILED |
| Friday, May 16, 2025 | SOU EXTENSION 3 GRANTED |
| Saturday, May 17, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
